1.310
+1,55%
2026-10-19
Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -11432.6% | -4389.5% | 0 / 3 | +31.6% | -14.50 pp | -68.51 pp | -97.6% | 5.12 | — | 312 | +31,6% | −210 | −6.660,8% | — | 83.07 | — |
| Pts | 0 | 0 | 0 | 12 | 0 | 0 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 1.310 (close price on 2026-10-19)EPS (TTM): −672,0
Financial charts
1.Revenue & growth
VND bn312Q2/26
1.Revenue & growth
VND bn312Q2/26
2.Profit & growth
VND bn-210Q2/26
3.Profit mix (Penman)
VND bn-277Q2/26
4.Margins & cost structure
%12.9%Q2/26
5.Returns & cash cycle
% · days-20.3%Q2/26
6.Earnings quality & cash
VND bn-120Q2/26
7.Asset structure
VND bn2.499Q2/26
8.Funding & debt health
VND bn · times2.499Q2/26
9.Revenue backlog
VND bn1.283Q2/26
10.Valuation
times · %-2,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-510Q2/26
Adjusted EPS growth, latest quarter
-11433%
Average adjusted EPS growth, 3 quarters
-4390%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26